NCT02006056 Ondissolve in the Prophylaxis/Rescue of Radiation Induced Nausea and Vomiting Status COMPLETED Phase PHASE2
NCT01987869 Hiperemezis and Serotonin Elevated Serum Serotonin Levels in Hyperemesis Status UNKNOWN Phase N/A
NCT01984931 Study of Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)for Treatment of Post Operative Nausea and Vomiting Status UNKNOWN Phase PHASE3
NCT01980160 Relief Band as an Adjunct to Antiemetic Therapy in Patients Who Receive Mod to Highly Emetogenic Chemotherapy Status WITHDRAWN Phase NA
NCT01895010 Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After TACE Status UNKNOWN Phase PHASE2
NCT01887314 Efficacy Study of Ginger (Zingiber Officinale) Extract "Ginpax" to Manage Nausea in Cancer Patients Receiving High Emetogenic Treatments and Standard Anti-emetogenic Therapy Status COMPLETED Phase NA
NCT01830881 Evaluation of Oral Midazolam in First-trimester Surgical Abortions Status COMPLETED Phase PHASE4
NCT01780428 Phase III Study of the Safety and Efficacy of Cl-108 in the Treatment of Moderate to Severe Pain Status COMPLETED Phase PHASE3
NCT01733771 The Effect of Complementary Medicine (CAM) Treatments on Common Symptoms in Hospitalized Patients Status COMPLETED Phase NA
NCT01733212 Efficacy of Ginger on Intraoperative and Postoperative Nausea and Vomiting in Elective Cesarean Section Patients Status COMPLETED Phase PHASE2/PHASE3
NCT01687751 Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients Status WITHDRAWN Phase PHASE2
NCT01684969 Evidence of Haloperidol Absorption After Topical Administration Status WITHDRAWN Phase EARLY_PHASE1
NCT01649258 Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy Status TERMINATED Phase PHASE1
NCT01643577 Acupuncture Treatment for Gastroparesis: a Pilot Study Status COMPLETED Phase PHASE1/PHASE2
NCT01636947 A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC) Status COMPLETED Phase PHASE4